sameAs
Zika virus outbreak and the case for building effective and sustainable rapid diagnostics laboratory capacity globallyFailure to detect Plasmodium vivax in West and Central Africa by PCR species typingMalaria epidemiological research in the Republic of CongoLearning from epidemiological, clinical and immunological studies on Mycobacterium africanum for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies and vaccStrong decrease in streptomycin-resistance and absence of XDR 12 years after the Reorganization of the National Tuberculosis Control Program in the Central Region of CameroonEnhancing preparedness for tackling new epidemic threats.The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications.Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries.Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region.EDCTP regional networks of excellence: initial merits for planned clinical trials in Africa.Malaria burden and case management in the Republic of Congo: limited use and application of rapid diagnostic tests results.Molecular surveillance of Plasmodium falciparum drug resistance in the Republic of Congo: four and nine years after the introduction of artemisinin-based combination therapy.Sequence analysis for detection of drug resistance in Mycobacterium tuberculosis complex isolates from the Central Region of Cameroon.Geographical distribution of complement receptor type 1 variants and their associated disease risk.Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomized trials performed in Sub-Saharan Africa.Prevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of CongoFine specificity of anti-MSP119 antibodies and multiplicity of Plasmodium falciparum merozoite surface protein 1 types in individuals in Nigeria with sub-microscopic infection.Africanizing scientific knowledge: the Multilateral Initiative on Malaria as a model?Malaria: a research agenda for the eradication era.Consensus standards for introductory e-learning courses in human participants research ethicsGenetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of CongoA thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon.Factors influencing acceptability of voluntary HIV testing among pregnant women in Gamboma, Republic of Congo.Diagnosis of smear-negative pulmonary tuberculosis based on clinical signs in the Republic of Congo.Genetic polymorphism of merozoite surface protein 2 and prevalence of K76T pfcrt mutation in Plasmodium falciparum field isolates from Congolese children with asymptomatic infections.Artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in Congolese children under 10 years old living in a suburban area: a randomized study.Imbalanced distribution of Plasmodium falciparum MSP-1 genotypes related to sickle-cell trait.Reduction of multiplicity of infections but no change in msp2 genetic diversity in Plasmodium falciparum isolates from Congolese children after introduction of artemisinin-combination therapy.Genetic evidence of regulatory gene variants of the STAT6, IL10R and FOXP3 locus as a susceptibility factor in uncomplicated malaria and parasitaemia in Congolese children.Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville.New interventions for malaria: mining the human and parasite genomes.In vitro evaluation of antiplasmodial activity of extracts of Acanthospermum hispidum DC (Asteraceae) and Ficus thonningii Blume (Moraceae), two plants used in traditional medicine in the Republic of Congo.Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, CongoHuman genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren.Towards host-directed therapies for tuberculosis.Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West Africa.Health systems in the Republic of Congo: challenges and opportunities for implementing tuberculosis and HIV collaborative service, research, and training activities.Plasmodium falciparum infection in febrile Congolese children: prevalence of clinical malaria 10 years after introduction of artemisinin-combination therapies.High prevalence of sulphadoxine-pyrimethamine resistance-associated mutations in Plasmodium falciparum field isolates from pregnant women in Brazzaville, Republic of Congo.
P50
Q24261384-621C54EF-3E70-4D71-8F54-515662DD1A3AQ24646965-8E7475AE-1D5D-40FD-855F-41716B72464BQ28068644-57615FFB-1BB0-459B-8E82-ADCF4F4AD1D5Q28078580-9A47A46F-EA48-40AF-B0B9-85214D1622EDQ28539416-E8467C47-6FA2-4DC7-B417-298F1602561DQ30148632-960A7FFA-3E22-4D55-AE63-2A7D51534644Q30236033-F891C1D7-6240-4F8F-9F97-BA8BD818AA64Q30240943-31860F69-B39B-4CD0-9D12-92169884984BQ30385577-A6B734C8-7C06-4615-9C7A-B3A597E78169Q30393945-E14B7F80-8C26-48A2-91AE-9F92286D52D0Q31111101-59493DB4-BC1A-4533-A806-E791192345F9Q33576812-7C0F2E39-6C3F-4EA4-AEAD-0308E05FF4C5Q33597327-2E52ED72-246A-4E3A-9361-DC52101BB7B0Q33698822-E593192E-75F5-4C72-88F5-1F405EC2AFA8Q33872061-C5ABD276-5ABB-476D-AE9D-25518EDCB720Q34203557-798481C2-5C4B-4777-B5E7-D969A6902A20Q34249359-0EA0CEF1-2CAE-414F-A389-19F5D48E4758Q34407209-7F4F1169-D1B3-43F7-BE08-61C16952251EQ35010688-F0783822-A278-4295-BA3D-01E2CC0889A2Q35343490-0AE4FD6C-9E3C-4306-8A13-DB616832D7ACQ35373925-F5529CA4-2422-4311-A859-00B3194AE4B6Q35549781-A1AD1ADE-2DD6-4313-9B79-2832AE60A08FQ35834748-0999C13A-9DED-4CCC-8A3F-CC3E25893813Q35873012-E37DE1A7-6E6A-4AE7-8284-54FB4F5E3BAEQ35950891-5619CD86-E718-44DE-B99A-600ED5C01C32Q36224152-888A34E1-DBAC-46B5-A78A-92F94823410EQ36437782-58BAA1C3-A5DF-455C-9983-EC9E1A3BA48CQ36526862-71A6459B-4C5F-431E-8FFA-CBDD064ECFCDQ36541823-3A92B321-5F71-4953-A08F-83CDEF06F77FQ36599445-73A5425C-C727-4DC0-BEC5-F8B3E2388D40Q37047642-DE33D46D-F3E9-4582-992D-5577C20D55C3Q37103018-6265D98A-9E54-42BE-AB90-E0D67BAE3483Q37588147-6F4120FF-0CCB-4409-8B59-68E31CE51A90Q37739659-47A8372B-784F-42DC-8D29-0DF8E72F91C1Q38356717-213AEA55-F817-469D-8185-7A1CD7690847Q38858468-6FA8E1B9-36D9-48EF-BA42-4F773A1F223FQ38876683-F418BB33-8200-468E-8DF8-03BA8AF39C35Q38877726-B03AC87E-2C7E-48DA-BBC6-9ED1C4DF5F13Q38996070-7010ABDE-F664-480A-832C-EEDB02151D0DQ39011910-EC157075-3798-4554-832A-118B6834F431
P50
description
Congolese parasitologist
@en
immunologe uit Congo-Brazzaville
@nl
scientifique congolaise spécialiste du paludisme
@fr
name
Francine Ntoumi
@ast
Francine Ntoumi
@br
Francine Ntoumi
@co
Francine Ntoumi
@da
Francine Ntoumi
@de
Francine Ntoumi
@en
Francine Ntoumi
@es
Francine Ntoumi
@fr
Francine Ntoumi
@id
Francine Ntoumi
@it
type
label
Francine Ntoumi
@ast
Francine Ntoumi
@br
Francine Ntoumi
@co
Francine Ntoumi
@da
Francine Ntoumi
@de
Francine Ntoumi
@en
Francine Ntoumi
@es
Francine Ntoumi
@fr
Francine Ntoumi
@id
Francine Ntoumi
@it
altLabel
F Ntoumi
@en
F. Ntoumi
@en
Ntoumi F
@en
Ntoumi F.
@en
Ntoumi
@en
prefLabel
Francine Ntoumi
@ast
Francine Ntoumi
@br
Francine Ntoumi
@co
Francine Ntoumi
@da
Francine Ntoumi
@de
Francine Ntoumi
@en
Francine Ntoumi
@es
Francine Ntoumi
@fr
Francine Ntoumi
@id
Francine Ntoumi
@it
P106
P166
P214
P269
P101
P1412
P166
P19
P21
P213
0000 0004 3095 0912
P214
P269
P27
P31
P569
1961-01-01T00:00:00Z
P735
P7859
viaf-190588346